Cargando…

Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation

BACKGROUND: MEF2C (Myocyte-specific enhancer factor 2C) has been associated with neurodevelopmental disorders. This study aimed at delineating the clinical profiles of MEF2C gene mutations. METHODS: In total, 112 Chinese patients with intellectual disability (ID) were recruited, including 44 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiaping, Zhang, Qingping, Chen, Yan, Yu, Shujie, Wu, Xiru, Bao, Xinhua, Wen, Yongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208086/
https://www.ncbi.nlm.nih.gov/pubmed/30376817
http://dx.doi.org/10.1186/s12881-018-0699-1
_version_ 1783366648765349888
author Wang, Jiaping
Zhang, Qingping
Chen, Yan
Yu, Shujie
Wu, Xiru
Bao, Xinhua
Wen, Yongxin
author_facet Wang, Jiaping
Zhang, Qingping
Chen, Yan
Yu, Shujie
Wu, Xiru
Bao, Xinhua
Wen, Yongxin
author_sort Wang, Jiaping
collection PubMed
description BACKGROUND: MEF2C (Myocyte-specific enhancer factor 2C) has been associated with neurodevelopmental disorders. This study aimed at delineating the clinical profiles of MEF2C gene mutations. METHODS: In total, 112 Chinese patients with intellectual disability (ID) were recruited, including 44 patients presented with Rett syndrome (RTT) or RTT-like syndrome, and 68 patients with non-syndromic ID. Targeted next-generation sequencing (NGS) was performed. Detailed clinical information was collected. RESULTS: Five heterozygous MEF2C gene mutations were identified, of which three were novel. The MEF2C mutant rate was 4.5% (5/112) in total, and 6.8% (3/44) in the RTT (−like) cohort. All patients with MEF2C gene mutation presented with cognitive impairment, gross motor delay, speech disorder and autistic features. Four patients had epilepsy, which responded well to antiepileptic drugs. One female was diagnosed with classical RTT, two females with RTT-like syndrome, and two males with non-syndromic ID. Generally, the phenotype of two males with relatively downstream mutations (c.565C > T, p.Arg 189*; c.766C > T, p.Arg 256*) was milder than that of three females with upstream mutations (c.48C > G, p.Asn16Lys; c.334G > T, p.Glu112* and c.403-1G > T). CONCLUSIONS: Our findings expanded the current understanding of the consequences of MEF2C dysfunctions, especially MEF2C point mutations. MEF2C mutations are associated with a broad clinical spectrum, ranged from classical RTT to non-syndromic ID. Through our study, it can be inferred that there is correlation between the phenotype and MEF2C-genotype, the mutation site. Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0699-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6208086
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62080862018-11-16 Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation Wang, Jiaping Zhang, Qingping Chen, Yan Yu, Shujie Wu, Xiru Bao, Xinhua Wen, Yongxin BMC Med Genet Research Article BACKGROUND: MEF2C (Myocyte-specific enhancer factor 2C) has been associated with neurodevelopmental disorders. This study aimed at delineating the clinical profiles of MEF2C gene mutations. METHODS: In total, 112 Chinese patients with intellectual disability (ID) were recruited, including 44 patients presented with Rett syndrome (RTT) or RTT-like syndrome, and 68 patients with non-syndromic ID. Targeted next-generation sequencing (NGS) was performed. Detailed clinical information was collected. RESULTS: Five heterozygous MEF2C gene mutations were identified, of which three were novel. The MEF2C mutant rate was 4.5% (5/112) in total, and 6.8% (3/44) in the RTT (−like) cohort. All patients with MEF2C gene mutation presented with cognitive impairment, gross motor delay, speech disorder and autistic features. Four patients had epilepsy, which responded well to antiepileptic drugs. One female was diagnosed with classical RTT, two females with RTT-like syndrome, and two males with non-syndromic ID. Generally, the phenotype of two males with relatively downstream mutations (c.565C > T, p.Arg 189*; c.766C > T, p.Arg 256*) was milder than that of three females with upstream mutations (c.48C > G, p.Asn16Lys; c.334G > T, p.Glu112* and c.403-1G > T). CONCLUSIONS: Our findings expanded the current understanding of the consequences of MEF2C dysfunctions, especially MEF2C point mutations. MEF2C mutations are associated with a broad clinical spectrum, ranged from classical RTT to non-syndromic ID. Through our study, it can be inferred that there is correlation between the phenotype and MEF2C-genotype, the mutation site. Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0699-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-30 /pmc/articles/PMC6208086/ /pubmed/30376817 http://dx.doi.org/10.1186/s12881-018-0699-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Jiaping
Zhang, Qingping
Chen, Yan
Yu, Shujie
Wu, Xiru
Bao, Xinhua
Wen, Yongxin
Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation
title Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation
title_full Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation
title_fullStr Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation
title_full_unstemmed Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation
title_short Novel MEF2C point mutations in Chinese patients with Rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation
title_sort novel mef2c point mutations in chinese patients with rett (−like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208086/
https://www.ncbi.nlm.nih.gov/pubmed/30376817
http://dx.doi.org/10.1186/s12881-018-0699-1
work_keys_str_mv AT wangjiaping novelmef2cpointmutationsinchinesepatientswithrettlikesyndromeornonsyndromicintellectualdisabilityinsightsintogenotypephenotypecorrelation
AT zhangqingping novelmef2cpointmutationsinchinesepatientswithrettlikesyndromeornonsyndromicintellectualdisabilityinsightsintogenotypephenotypecorrelation
AT chenyan novelmef2cpointmutationsinchinesepatientswithrettlikesyndromeornonsyndromicintellectualdisabilityinsightsintogenotypephenotypecorrelation
AT yushujie novelmef2cpointmutationsinchinesepatientswithrettlikesyndromeornonsyndromicintellectualdisabilityinsightsintogenotypephenotypecorrelation
AT wuxiru novelmef2cpointmutationsinchinesepatientswithrettlikesyndromeornonsyndromicintellectualdisabilityinsightsintogenotypephenotypecorrelation
AT baoxinhua novelmef2cpointmutationsinchinesepatientswithrettlikesyndromeornonsyndromicintellectualdisabilityinsightsintogenotypephenotypecorrelation
AT wenyongxin novelmef2cpointmutationsinchinesepatientswithrettlikesyndromeornonsyndromicintellectualdisabilityinsightsintogenotypephenotypecorrelation